INSIGHTS ON CELL & GENE THERAPY LOGISTICS

• U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact

  Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

• Active Versus Passive Shipping Solutions For Clinical Shipments

  Explore active and passive temperature-controlled shipping solutions and their impact on clinical trial supply, balancing cost, risk, and product integrity.

• Sourcing, Analyzing, And Ensuring Quality In CGT Raw Materials

  Biopharmaceutical sponsors should utilize phase-appropriate strategies to mitigate risks like material variability and regulatory scrutiny in cell and gene therapy development. These proactive measures ensure quality and supply chain security, stabilizing delivery of these complex treatments despite significant cost and consistency challenges.

• Evolving Methods Of Bulk Freezing

  Learn how the transition to plate-based freezing with single-use technologies improves scalability and contamination control while ensuring uniform thermal transfer for high-value bulk drug substances.

• ProConnex® Single-Use Bags

  State-of-the-art flexible and rigid single-use bags engineered specifically for bioprocessing applications. Optimize handling and transfer of high-value liquids with our range of bottles, carboys, 2D bags, and 3D bags.

• Single-Use Solutions: Biological Fluid Management

  Ensure efficiency in your upstream and downstream biopharma workflows with Charter Medical’s biological fluid management solutions.

• Single-Use Solutions: Cell Growth

  From early-stage research to commercial-scale production, Charter Medical delivers integrated solutions that streamline your biopharma workflows.

• Single-Use Solutions: Cryopreservation

  As advanced therapy manufacturing evolves, maintaining the integrity of biological materials during cryopreservation steps is ever more critical.

• DEHP-Free CryoProtect™ Bio-Containers

  Charter Medical’s DEHP-free CryoProtect™ Bio-Containers are designed for intermediate, final fill, storage, and transport in bioprocessing applications using compatible freezing cassettes.

• Cell Freeze® Cryogenic Storage Containers

  Charter Medical’s Cell Freeze® cryogenic storage containers are designed for storage, preservation, and transfer of hematopoietic cells (HPC) in liquid nitrogen to -196ºC. The Cell Freeze® Liquid Nitrogen Freezing Container is provided sterile (fluid path) by gamma irradiation and intended for single use. Do not reuse. Reuse causes contamination of the interior fluid path.